Regulations/Policies - Page 24 of 29 - Express Pharma

Emergency authorisation for COVID-19 vaccine possible if government decides: ICMR

NPPA rejects IPA request for upward price revision of five per cent on all drugs

US FDA publishes compliance policy for quantity of samples retained for BA and BE studies

Gujarat FDCA to suspend product licenses of over 70 hand sanitisers

D&C Act 1940 should be reframed: Pharma stakeholders

Pharma industry requests government to delay release of new NLEM list

CanSino gets COVID-19 vaccine patent from China’s IP regulator

NPPA issues final guidelines to discontinue making medicines under price control

Pharma-telehealth partnerships: Rules of the game

NPPA sets up Price Monitoring and Resource Unit in Karnataka